Brefoville #10 Capsule

Composition:

• Saccharomyces boulardii 0.25 x 10⁹ CFU

• Lactobacillus rhamnosus 0.25 x 10⁹ CFU

• Zinc 10 mg

• Inulin 200 mg

Pharmacological properties:Saccharomyces boulardii stimulates the secretion of immunoglobulin A (IgA-x), enhancing local immunity. When used together with antibiotic therapy, it helps maintain the balance of bacterial flora until the end of treatment. Lactobacillus rhamnosus is a probiotic resistant to gastric acid. Clinical studies have confirmed the effectiveness of this strain in travelers’ diarrhea and post-antibiotic therapy diarrhea.

Brefoville can also be used in acute gastroenteritis for rehydration therapy. It protects the intestines from exacerbation of pseudomembranous colitis. Reduces the risk of gingivitis and periodontal disease development. Acts as an adjuvant during H. pylori eradication.

Indications:

• Treatment and prevention of acute infectious, viral, and bacterial diarrhea

• Post-antibiotic therapy period

• Gastrointestinal infections

• H. pylori eradication

Dosage:Take 1 capsule of Brefoville once daily

Duration:7-10 days

The drug is indicated for use in pregnant women, during lactation, and in elderly patients

Contraindications:Increased sensitivity to the components of the drug

No side effects have been reported during the use of the product.

Warning and storage conditions:Store in a dry, cool place, protected from light, at a temperature not exceeding 25°C

Shelf life is indicated on the box.

Dosage form:Capsule #10

Dispensing rules:Available without prescription

Manufacturer:LTD “Honor ILAC”, Turkey
Official distributor in Georgia:LTD “El Company”